Not Yet RecruitingNCT07816315
Phase 3 Study of Intravitreal OLN324 in Adults With Neovascular (Wet) Age-related Macular Degeneration (nAMD) (OLN324-CP-04)
PHASE3 · 500 planned enrolment
- Countries listed
- 0
- Registry update
- September 11, 2026
Registry Intervention View
OLN324
Trial registrations containing the exact intervention label OLN324.
Exact registry label · Not reported
3 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
0 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
Not Yet RecruitingNCT07816289
Phase 3 Study of Intravitreal OLN324 in Adults With Neovascular (Wet) Age-related Macular Degeneration (nAMD) (OLN324-CP-05)
PHASE3 · 400 planned enrolment
- Countries listed
- 0
- Registry update
- September 11, 2026
CompletedNCT07484074
A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324
PHASE1 · 164 planned enrolment
- Countries listed
- 2
- Registry update
- March 19, 2026